These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. High EVI1 expression predicts poor survival in acute myeloid leukemia: a study of 319 de novo AML patients. Barjesteh van Waalwijk van Doorn-Khosrovani S; Erpelinck C; van Putten WL; Valk PJ; van der Poel-van de Luytgaarde S; Hack R; Slater R; Smit EM; Beverloo HB; Verhoef G; Verdonck LF; Ossenkoppele GJ; Sonneveld P; de Greef GE; Löwenberg B; Delwel R Blood; 2003 Feb; 101(3):837-45. PubMed ID: 12393383 [TBL] [Abstract][Full Text] [Related]
3. Ecotropic virus integration site-1 gene preferentially expressed in post-myelodysplasia acute myeloid leukemia: possible association with GATA-1, GATA-2, and stem cell leukemia gene expression. Ohyashiki JH; Ohyashiki K; Shimamoto T; Kawakubo K; Fujimura T; Nakazawa S; Toyama K Blood; 1995 Jun; 85(12):3713-8. PubMed ID: 7780155 [TBL] [Abstract][Full Text] [Related]
4. Aberrant expression of ecotropic viral integration site-1 in acute myeloid leukemia and acute lymphoblastic leukemia. Su G; Lian X; Tan D; Tao H; Liu H; Chen S; Yin H; Wu D; Yin B Leuk Lymphoma; 2015 Feb; 56(2):472-9. PubMed ID: 24828867 [TBL] [Abstract][Full Text] [Related]
5. Expression of EVI1 in myelodysplastic syndromes and other hematologic malignancies without 3q26 translocations. Russell M; List A; Greenberg P; Woodward S; Glinsmann B; Parganas E; Ihle J; Taetle R Blood; 1994 Aug; 84(4):1243-8. PubMed ID: 8049440 [TBL] [Abstract][Full Text] [Related]
6. Amplification and translocation of 3q26 with overexpression of EVI1 in Fanconi anemia-derived childhood acute myeloid leukemia with biallelic FANCD1/BRCA2 disruption. Meyer S; Fergusson WD; Whetton AD; Moreira-Leite F; Pepper SD; Miller C; Saunders EK; White DJ; Will AM; Eden T; Ikeda H; Ullmann R; Tuerkmen S; Gerlach A; Klopocki E; Tönnies H Genes Chromosomes Cancer; 2007 Apr; 46(4):359-72. PubMed ID: 17243162 [TBL] [Abstract][Full Text] [Related]
7. Low expression of MDS1-EVI1-like-1 (MEL1) and EVI1-like-1 (EL1) genes in favorable-risk acute myeloid leukemia. Barjesteh van Waalwijk van Doorn-Khosrovani S; Erpelinck C; Löwenberg B; Delwel R Exp Hematol; 2003 Nov; 31(11):1066-72. PubMed ID: 14585371 [TBL] [Abstract][Full Text] [Related]
8. High EVI1 levels predict adverse outcome in acute myeloid leukemia: prevalence of EVI1 overexpression and chromosome 3q26 abnormalities underestimated. Lugthart S; van Drunen E; van Norden Y; van Hoven A; Erpelinck CA; Valk PJ; Beverloo HB; Löwenberg B; Delwel R Blood; 2008 Apr; 111(8):4329-37. PubMed ID: 18272813 [TBL] [Abstract][Full Text] [Related]
9. Forced expression of the leukemia-associated gene EVI1 in ES cells: a model for myeloid leukemia with 3q26 rearrangements. Sitailo S; Sood R; Barton K; Nucifora G Leukemia; 1999 Nov; 13(11):1639-45. PubMed ID: 10557037 [TBL] [Abstract][Full Text] [Related]
10. Expression and prognostic significance of different mRNA 5'-end variants of the oncogene EVI1 in 266 patients with de novo AML: EVI1 and MDS1/EVI1 overexpression both predict short remission duration. Haas K; Kundi M; Sperr WR; Esterbauer H; Ludwig WD; Ratei R; Koller E; Gruener H; Sauerland C; Fonatsch C; Valent P; Wieser R Genes Chromosomes Cancer; 2008 Apr; 47(4):288-98. PubMed ID: 18181178 [TBL] [Abstract][Full Text] [Related]
11. [EVI1 expression, clinical and cytogenetical characteristics in 447 patients with acute myeloid leukemia]. He XF; Wang QR; Cen JN; Qiu HY; Sun AN; Chen SN; Wu DP Zhonghua Xue Ye Xue Za Zhi; 2016 Nov; 37(11):936-941. PubMed ID: 27995876 [TBL] [Abstract][Full Text] [Related]
12. An interphase fluorescence in situ hybridisation assay for the detection of 3q26.2/EVI1 rearrangements in myeloid malignancies. Bobadilla D; Enriquez EL; Alvarez G; Gaytan P; Smith D; Slovak ML Br J Haematol; 2007 Mar; 136(6):806-13. PubMed ID: 17341266 [TBL] [Abstract][Full Text] [Related]
13. Three novel cytogenetically cryptic EVI1 rearrangements associated with increased EVI1 expression and poor prognosis identified in 27 acute myeloid leukemia cases. Haferlach C; Bacher U; Grossmann V; Schindela S; Zenger M; Kohlmann A; Kern W; Haferlach T; Schnittger S Genes Chromosomes Cancer; 2012 Dec; 51(12):1079-85. PubMed ID: 22887804 [TBL] [Abstract][Full Text] [Related]
14. The EVI1 gene in myeloid leukemia. Nucifora G Leukemia; 1997 Dec; 11(12):2022-31. PubMed ID: 9447815 [TBL] [Abstract][Full Text] [Related]
15. Intergenic splicing of MDS1 and EVI1 occurs in normal tissues as well as in myeloid leukemia and produces a new member of the PR domain family. Fears S; Mathieu C; Zeleznik-Le N; Huang S; Rowley JD; Nucifora G Proc Natl Acad Sci U S A; 1996 Feb; 93(4):1642-7. PubMed ID: 8643684 [TBL] [Abstract][Full Text] [Related]
16. High EVI1 expression is associated with MLL rearrangements and predicts decreased survival in paediatric acute myeloid leukaemia: a report from the children's oncology group. Ho PA; Alonzo TA; Gerbing RB; Pollard JA; Hirsch B; Raimondi SC; Cooper T; Gamis AS; Meshinchi S Br J Haematol; 2013 Sep; 162(5):670-7. PubMed ID: 23826732 [TBL] [Abstract][Full Text] [Related]
17. Acute promyelocytic leukemia relapsing as secondary acute myelogenous leukemia with translocation t(3;21)(q26;q22) and RUNX1-MDS1-EVI1 fusion transcript. Park TS; Choi JR; Yoon SH; Song J; Kim J; Kim SJ; Kwon O; Min YH Cancer Genet Cytogenet; 2008 Dec; 187(2):61-73. PubMed ID: 19027486 [TBL] [Abstract][Full Text] [Related]
18. Promoter-centred chromatin interactions associated with EVI1 expression in EVI1+3q- myeloid leukaemia cells. Ng HL; Robinson ME; May PC; Innes AJ; Hiemeyer C; Feldhahn N Br J Haematol; 2024 Mar; 204(3):945-958. PubMed ID: 38296260 [TBL] [Abstract][Full Text] [Related]
19. Diabetes insipidus as first manifestation of acute myeloid leukaemia with EVI-1-positive, 3q21q26 syndrome and T cell-line antigen expression: what is the EVI-1 gene role? Breccia M; Petti MC; Ottaviani E; Mancini M; D'Elia GM; Mecarocci S; Alimena G Br J Haematol; 2002 Aug; 118(2):438-41. PubMed ID: 12139729 [TBL] [Abstract][Full Text] [Related]
20. The leukemic oncogene EVI1 hijacks a MYC super-enhancer by CTCF-facilitated loops. Ottema S; Mulet-Lazaro R; Erpelinck-Verschueren C; van Herk S; Havermans M; Arricibita Varea A; Vermeulen M; Beverloo HB; Gröschel S; Haferlach T; Haferlach C; J Wouters B; Bindels E; Smeenk L; Delwel R Nat Commun; 2021 Sep; 12(1):5679. PubMed ID: 34584081 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]